| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Jaya Sharma, M Tariq Bhatti, Helen V Danesh-Meye. Neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein IgG associated disorder: A comprehensive neuro-ophthalmic review. Clinical & experimental ophthalmology. vol 49. issue 2. 2021-08-31. PMID:33426799. |
neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein igg associated disorder: a comprehensive neuro-ophthalmic review. |
2021-08-31 |
2023-08-13 |
Not clear |
| Scott D Newsome, Anne H Cross, Robert J Fox, June Halper, Pamela Kanellis, Bruce Bebo, David Li, Gary R Cutter, Kottil W Rammohan, Amber Salte. COVID-19 in Patients With Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody Disease in North America: From the COViMS Registry. Neurology(R) neuroimmunology & neuroinflammation. vol 8. issue 5. 2021-08-30. PMID:34429342. |
covid-19 in patients with neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody disease in north america: from the covims registry. |
2021-08-30 |
2023-08-13 |
Not clear |
| Scott D Newsome, Anne H Cross, Robert J Fox, June Halper, Pamela Kanellis, Bruce Bebo, David Li, Gary R Cutter, Kottil W Rammohan, Amber Salte. COVID-19 in Patients With Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody Disease in North America: From the COViMS Registry. Neurology(R) neuroimmunology & neuroinflammation. vol 8. issue 5. 2021-08-30. PMID:34429342. |
to describe the impact of coronavirus disease 2019 (covid-19) on people with neuromyelitis optica spectrum disorders (nmosd) and myelin oligodendrocyte glycoprotein antibody disease (mogad). |
2021-08-30 |
2023-08-13 |
Not clear |
| Judith Derdelinckx, Tatjana Reynders, Inez Wens, Nathalie Cools, Barbara Willeken. Cells to the Rescue: Emerging Cell-Based Treatment Approaches for NMOSD and MOGAD. International journal of molecular sciences. vol 22. issue 15. 2021-08-25. PMID:34360690. |
cell-based therapies are gaining momentum as promising treatments for rare neurological autoimmune diseases, including neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated disease. |
2021-08-25 |
2023-08-13 |
human |
| Xindi Li, Chengyi Zhang, Dongmei Jia, Moli Fan, Ting Li, De-Cai Tian, Yaou Liu, Fu-Dong Sh. The occurrence of myelin oligodendrocyte glycoprotein antibodies in aquaporin-4-antibody seronegative Neuromyelitis Optica Spectrum Disorder: A systematic review and meta-analysis. Multiple sclerosis and related disorders. vol 53. 2021-08-24. PMID:34118585. |
the occurrence of myelin oligodendrocyte glycoprotein antibodies in aquaporin-4-antibody seronegative neuromyelitis optica spectrum disorder: a systematic review and meta-analysis. |
2021-08-24 |
2023-08-13 |
Not clear |
| Xindi Li, Chengyi Zhang, Dongmei Jia, Moli Fan, Ting Li, De-Cai Tian, Yaou Liu, Fu-Dong Sh. The occurrence of myelin oligodendrocyte glycoprotein antibodies in aquaporin-4-antibody seronegative Neuromyelitis Optica Spectrum Disorder: A systematic review and meta-analysis. Multiple sclerosis and related disorders. vol 53. 2021-08-24. PMID:34118585. |
despite inclusion in neuromyelitis optica spectrum disorders (nmosd), myelin oligodendrocyte glycoprotein antibody (mog-ab)-associated diseases are increasingly recognized as an independent disease entity. |
2021-08-24 |
2023-08-13 |
Not clear |
| Yukino Miyachi, Takayuki Fujii, Ryo Yamasaki, Daisuke Tsuchimoto, Kyoko Iinuma, Ayako Sakoda, Shoko Fukumoto, Takuya Matsushita, Katsuhisa Masaki, Noriko Isobe, Yusaku Nakabeppu, Jun-Ichi Kir. Serum Anti-oligodendrocyte Autoantibodies in Patients With Multiple Sclerosis Detected by a Tissue-Based Immunofluorescence Assay. Frontiers in neurology. vol 12. 2021-08-24. PMID:34421790. |
we assessed the binding of serum autoantibodies to mouse oligodendrocytes expressing nogo-a, a reliable mature oligodendrocyte marker, by ifa with mouse brain and sera from 147 ms patients, comprising 103 relapsing-remitting ms (rrms), 22 secondary progressive ms (spms), and 22 primary progressive ms (ppms) patients, 38 neuromyelitis optica spectrum disorder (nmosd) patients, 23 other inflammatory neurological disorder (oind) patients, and 39 healthy controls (hcs). |
2021-08-24 |
2023-08-13 |
mouse |
| Solène Dauby, Dominique Dive, Laurence Lutteri, Cécile Andris, Isabelle Hansen, Pierre Maquet, Emilie Lommer. Comparative study of AQP4-NMOSD, MOGAD and seronegative NMOSD: a single-center Belgian cohort. Acta neurologica Belgica. 2021-08-17. PMID:34097296. |
to emphasize physio-pathological, clinical and prognosis differences between conditions causing serious and sometimes very similar clinical manifestations: anti-aquaporin-4 (aqp4) and anti-myelin oligodendrocyte glycoprotein (mog) antibodies related diseases, and seronegative nmosd (neuromyelitis optica spectrum disorders). |
2021-08-17 |
2023-08-13 |
Not clear |
| Jingzi ZhangBao, Wenjuan Huang, Lei Zhou, Liang Wang, Xuechun Chang, Chuanzhen Lu, Chongbo Zhao, Jiahong Lu, Chao Qua. Myelitis in inflammatory disorders associated with myelin oligodendrocyte glycoprotein antibody and aquaporin-4 antibody: A comparative study in Chinese Han patients. European journal of neurology. vol 28. issue 4. 2021-08-12. PMID:33220172. |
myelitis is an important clinical component of myelin oligodendrocyte glycoprotein antibody (mog-ab)-associated disease (mogad) and aquaporin-4 antibody (aqp4-ab)-positive neuromyelitis optica spectrum disorder (nmosd). |
2021-08-12 |
2023-08-13 |
Not clear |
| Marc Pawlitzki, Sigrid Ahring, Leoni Rolfes, Rainer Dziewas, Tobias Warnecke, Sonja Suntrup-Krueger, Heinz Wiendl, Luisa Klotz, Sven G Meuth, Bendix Labei. Dysphagia in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody disease as a surrogate of brain involvement? European journal of neurology. vol 28. issue 5. 2021-08-12. PMID:33338309. |
dysphagia in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody disease as a surrogate of brain involvement? |
2021-08-12 |
2023-08-13 |
Not clear |
| Marc Pawlitzki, Sigrid Ahring, Leoni Rolfes, Rainer Dziewas, Tobias Warnecke, Sonja Suntrup-Krueger, Heinz Wiendl, Luisa Klotz, Sven G Meuth, Bendix Labei. Dysphagia in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody disease as a surrogate of brain involvement? European journal of neurology. vol 28. issue 5. 2021-08-12. PMID:33338309. |
neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein antibody disease (mogad) are demyelinating disorders that typically affect the optic nerves and the spinal cord. |
2021-08-12 |
2023-08-13 |
Not clear |
| Haojie Xie, Yingzhe Shao, Juan Du, Yajun Song, Yanfei Li, Ranran Duan, Yaobing Yao, Zhe Gong, Junfang Teng, Yanjie Ji. Comparative analysis of clinical and imaging data between patients with myelin oligodendrocyte glycoprotein antibody disease and patients with aquaporin 4 antibody-positive neuromyelitis optica spectrum disorder. Journal of neurology. 2021-08-12. PMID:34383114. |
comparative analysis of clinical and imaging data between patients with myelin oligodendrocyte glycoprotein antibody disease and patients with aquaporin 4 antibody-positive neuromyelitis optica spectrum disorder. |
2021-08-12 |
2023-08-13 |
Not clear |
| Haojie Xie, Yingzhe Shao, Juan Du, Yajun Song, Yanfei Li, Ranran Duan, Yaobing Yao, Zhe Gong, Junfang Teng, Yanjie Ji. Comparative analysis of clinical and imaging data between patients with myelin oligodendrocyte glycoprotein antibody disease and patients with aquaporin 4 antibody-positive neuromyelitis optica spectrum disorder. Journal of neurology. 2021-08-12. PMID:34383114. |
we aimed to compare the clinical data, laboratory findings, and imaging characteristics of myelin oligodendrocyte glycoprotein antibody disease (mogad) and aquaporin 4 antibody (aqp4)-positive neuromyelitis optica spectrum disorder (nmosd), as detailed comparative analyses of laboratory data for both diseases are rare. |
2021-08-12 |
2023-08-13 |
Not clear |
| Virender Sachdeva, Ramesh Kekunnay. Working up a child with demyelinating optic neuritis: Striking a balance! Oman journal of ophthalmology. vol 14. issue 2. 2021-08-06. PMID:34345139. |
although it might often be postinfectious or postvaccination, recent understanding and available evidence suggest that it can be the first manifestation of a neuro-inflammatory syndrome such as multiple sclerosis, neuromyelitis optica spectrum disorder, acute disseminated encephalomyelitis or myelin oligodendrocyte glycoprotein associated optic neuritis. |
2021-08-06 |
2023-08-13 |
Not clear |
| Joseph A Lopez, Martina Denkova, Sudarshini Ramanathan, Russell C Dale, Fabienne Brilo. Pathogenesis of autoimmune demyelination: from multiple sclerosis to neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated disease. Clinical & translational immunology. vol 10. issue 7. 2021-08-03. PMID:34336206. |
pathogenesis of autoimmune demyelination: from multiple sclerosis to neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated disease. |
2021-08-03 |
2023-08-13 |
human |
| Joseph A Lopez, Martina Denkova, Sudarshini Ramanathan, Russell C Dale, Fabienne Brilo. Pathogenesis of autoimmune demyelination: from multiple sclerosis to neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated disease. Clinical & translational immunology. vol 10. issue 7. 2021-08-03. PMID:34336206. |
multiple sclerosis (ms), neuromyelitis optica spectrum disorders (nmosd) and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) are now recognised as separate disease entities under the amalgam of human central nervous system demyelinating disorders. |
2021-08-03 |
2023-08-13 |
human |
| Hyunjin Kim, Eun-Jae Lee, Seungmi Kim, Lyn-Kyung Choi, Keonwoo Kim, Hye Weon Kim, Kwang-Kuk Kim, Young-Min Li. Serum biomarkers in myelin oligodendrocyte glycoprotein antibody-associated disease. Neurology(R) neuroimmunology & neuroinflammation. vol 7. issue 3. 2021-08-02. PMID:32184342. |
to test the hypothesis that the pattern of serum biomarkers of disease activity and disability in myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) will be different from those in neuromyelitis optica spectrum disorder (nmosd) with anti-aquaporin-4 antibodies (aqp4-abs). |
2021-08-02 |
2023-08-13 |
Not clear |
| Arlette L Bruijstens, Yu Yi M Wong, Daniëlle E van Pelt, Pieter J E van der Linden, Geert W Haasnoot, Rogier Q Hintzen, Frans H J Claas, Rinze F Neuteboom, Beatrijs H A Wokk. HLA association in MOG-IgG- and AQP4-IgG-related disorders of the CNS in the Dutch population. Neurology(R) neuroimmunology & neuroinflammation. vol 7. issue 3. 2021-08-02. PMID:32198229. |
to investigate the possible human leukocyte antigen (hla) association of both myelin oligodendrocyte glycoprotein (mog-igg)-associated diseases (mogad) and aquaporin-4 antibody (aqp4-igg)-positive neuromyelitis optica spectrum disorders (nmosds) in the dutch population with european ancestry to clarify similarities or differences in the immunogenetic background of both diseases. |
2021-08-02 |
2023-08-13 |
human |
| Philippe A Bilodeau, Vinayak Kumar, Andrew E Rodriguez, Clarence T Li, Catalina Sanchez-Alvarez, Uma Thanarajasingam, Nicholas L Zalewski, Eoin P Flanaga. MOG-IgG myelitis coexisting with systemic lupus erythematosus in the post-partum setting. Multiple sclerosis (Houndmills, Basingstoke, England). vol 26. issue 8. 2021-07-28. PMID:31621483. |
longitudinally extensive transverse myelitis (letm) accompanying systemic lupus erythematosus (sle) is often due to coexisting aquaporin-4-igg seropositive neuromyelitis optica spectrum disorder but has not been associated with myelin oligodendrocyte glycoprotein-igg (mog-igg). |
2021-07-28 |
2023-08-13 |
Not clear |
| Sven Jarius, Hannah Pellkofer, Nadja Siebert, Mirjam Korporal-Kuhnke, Martin W Hümmert, Marius Ringelstein, Paulus S Rommer, Ilya Ayzenberg, Klemens Ruprecht, Luisa Klotz, Nasrin Asgari, Tobias Zrzavy, Romana Höftberger, Rafik Tobia, Mathias Buttmann, Kai Fechner, Kathrin Schanda, Martin Weber, Susanna Asseyer, Jürgen Haas, Christian Lechner, Ingo Kleiter, Orhan Aktas, Corinna Trebst, Kevin Rostasy, Markus Reindl, Tania Kümpfel, Friedemann Paul, Brigitte Wildeman. Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients. Journal of neuroinflammation. vol 17. issue 1. 2021-07-21. PMID:32883348. |
new-generation cell-based assays have demonstrated a robust association of serum autoantibodies to full-length human myelin oligodendrocyte glycoprotein (mog-igg) with (mostly recurrent) optic neuritis, myelitis, and brainstem encephalitis, as well as with neuromyelitis optica (nmo)-like or acute-disseminated encephalomyelitis (adem)-like presentations. |
2021-07-21 |
2023-08-13 |
human |